Jonathan J. Darrow, Jerry Avorn, M.D., and Aaron S. Kesselheim
New England Journal of Medicine
2014; 370:1252-1258March 27, 2014DOI: 10.1056/NEJMhle1311493
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes. [free full text]
Ellis et al. Journal of Clinical Oncology.
JAMA Study Shows Deep Public Mistrust in FDA, Belief Agency is Suppressing Cures
Alexander Gaffney (Regulatory Focus)
This summary contains a link to the original JAMA article.
Critical Evaluation of Disease Stabilization As a Measure of Activity of Systemic Therapy: Lessons From Trials With Arms in Which Patients Do Not Receive Active Treatment
[free full text]
Le Tourneau et al. Journal of Clinical Oncology
2014 Jan 20;32(3):260-3. doi: 10.1200/JCO.2013.53.5518. Epub 2013 Dec 2.
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Rui Wang et al. New England Journal of Medicine [free full text]
2007; 357:2189-2194November 22, 2007DOI: 10.1056/NEJMsr077003